Retinoid-related orphan receptor g (RORg) is an orphan nuclear hormone receptor (NR) that is preferentially expressed in skeletal muscle and several other tissues, including pancreas, thymus, prostate, liver and testis. Surprisingly, the specific role of RORg in skeletal muscle, a peripheral tissue, has not been examined. Muscle is one of the most energy demanding tissues which accounts for w40% of the total body mass and energy expenditure, O75% of glucose disposal and relies heavily on b-oxidation of fatty acids. We hypothesize that RORg regulates metabolism in this major mass lean tissue. This hypothesis was examined by gain and loss of function studies in an in vitro mouse skeletal muscle cell culture model. We show that RORg mRNA and protein are dramatically induced during skeletal muscle cell differentiation. We utilize stable ectopic over-expression of VP16-RORg (gain of function), native RORg and RORgDH12 (loss of function) vectors to modulate RORg mRNA expression and function. Ectopic VP16 (herpes simplex virus transcriptional activator)-RORg and native RORg expression increases RORa mRNA expression. Candidate-driven expression profiling of lines that ectopically express the native and variant forms of RORg suggested that this orphan NR has a function in regulating the expression of genes that control lipid homeostasis (fatty acid-binding protein 4, CD36 (fatty acid translocase), lipoprotein lipase and uncoupling protein 3), carbohydrate metabolism (GLUT5 (fructose transporter), adiponectin receptor 2 and interleukin 15 (IL-15)) and muscle mass . Surprisingly, the investigation revealed a function for RORg in the pathway that regulates production of reactive oxygen species.
Introduction
Nuclear hormone receptors (NRs) have been demonstrated to regulate metabolism in an organ-specific manner. The importance of NRs in the context of promoting and maintaining human health is underscored by the therapeutic utility of drugs that target dysfunctional hormone signalling in the context of human disease. NRs function as ligand-dependent DNA-binding proteins which translate physiological/ nutritional/metabolic signals into gene regulation. The NR superfamily includes the 'orphan NRs', which have no recognized ligands in the 'orthodox sense'.
The orphan nuclear receptor NR1F subgroup, retinoic acid receptor-related orphan receptor (ROR/RZR) includes three ROR/RZR genes; RORa encodes four RORa isoforms and is predominantly expressed in blood, brain, skeletal muscle and fat cells (Becker-Andre et al. 1993 . RORb/RZRb is expressed specifically in the brain (Carlberg et al. 1994) , and RORg encodes two isoforms RORg1 and RORgt. RORg1 is preferentially expressed in skeletal muscle and several other tissues, including pancreas, thymus, prostate, liver and testis of human (Hirose et al. 1994 , Ortiz et al. 1995 . RORgt isoform lacks 20 amino acids at amino terminus and is restricted to thymocytes (He et al. 1998) .
The NR1F subgroup is closely related to the NR1D subgroup, including Rev-erba, Rvr/Rev-erbb and the Drosophila orphan receptor, E75A, particularly in the DNA-binding domain and the putative ligand-binding domain. ROR, Rev-erba and RVR bind as monomers to an asymmetric (A/T) 6 RGGTCA motif. ROR functions as a constitutive transactivator of gene expression, whereas Rev-erba and RVR do not activate transcription, rather they mediate transcriptional repression, and can repress RORa-mediated transactivation from this motif (Harding & Lazar 1993 , Bonnelye et al. 1994 , Dumas et al. 1994 , Forman et al. 1994 , Retnakaran et al. 1994 , Adelmant et al. 1996 .
In vivo and in vitro (cell culture) genetic studies have implicated RORa in the regulation of lipid homeostasis. First, NR1F1 (RORa)-deficient mice have a dyslipidaemic phenotype, hypo-a-lipoproteinaemia, muscular atrophy and heightened inflammatory responses which lead to atherosclerosis (Vu-Dac et al. 1997 , Mamontova et al. 1998 , Raspe et al. 1999 , Jetten & Ueda 2002 , Jetten 2004 ). Secondly, ectopic over-expression of RORaDDE in a muscle cell culture model (Lau et al. 2004) leads to the modulation of genes involved in lipid absorption and b-oxidation. RORa (NR1F1) and Rev-erba (NR1D1) opposingly regulate the expression of apolipoprotein CIII, a component of high density lipoprotein (HDL) and very low density lipoprotein (VLDL) that regulates triglyceride (TG) levels and lipoprotein lipase (LPL) activity (Vu-Dac et al. 1997 , He et al. 1998 , Mamontova et al. 1998 , Raspe et al. 1999 .
Characterization of RORg K/K mice, identified several important immunological functions for RORg, in the control of lymph node and Peyer's patch development, thymopoiesis and T cell homeostasis. RORg K/K mice display increased apoptosis in the cortex of the thymus, and RORg K/K thymocytes placed in culture rapidly undergo apoptosis (Kurebayashi et al. 2000) .
RORg is highly expressed in skeletal muscle (Hirose et al. 1994) . Muscle accounts for w40% of the total body mass and energy expenditure, and O 75% of glucose disposal (Baron et al. 1988) . This lean tissue relies heavily on b-oxidation of fatty acids to supply the extreme energy demands of this organ. However, the fundamental role of RORg in skeletal muscle lipid and energy homeostasis has not been addressed. We hypothesize that RORg regulates metabolism in this major mass lean tissue. This hypothesis was tested by ectopic stable over-expression of RORg 'gain and loss' of function vectors in an in vitro mouse skeletal muscle cell culture model. These studies demonstrated that RORg has a role in controlling the expression of genes that regulate muscle and fat mass (including myostatin and interleukin 15 (IL-15)), and lipid homeostasis (fatty acid-binding protein 4 (FABP4), CD36 and LPL). Unexpectedly, the study demonstrated a role for RORg in the regulation of reactive oxygen species (ROS) production.
Materials and methods

Cell culture
Mouse myogenic C2C12 cells were cultured in growth medium called Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated Serum Supreme (Cambrex Bio Science, Mt. Waverly, Victoria, Australia) in 6% CO 2 . Confluent myoblasts were differentiated into post-mitotic multinucleated myotubes by 5 days (MT5) of serum withdrawal (i.e. cultured in DMEM supplemented with 2% horse serum). Cells were harvested at the indicated time points, usually 24-120 h (1-5 days) after mitogen withdrawal, unless indicated differently. African green monkey kidney COS-1 cells were grown in DMEM supplemented with 10% heatinactivated fetal calf serum.
RNA extraction and cDNA synthesis
Total RNA was extracted from C2C12 cells using TRIReagent (Sigma-Aldrich) according to manufacturer's protocol. Total RNA was then treated with 2 U Turbo DNase 1 (Ambion, Austin, TX, USA) at 37 8C for 30 min followed by purification of the RNA through an RNeasy purification column system (Qiagen). RNA was electrophoresed to determine the integrity of the preparation. SuperScript III was used to synthesize cDNA from 3 mg total RNA using random hexamers according to manufacturer's instructions (Invitrogen). The cDNA was then diluted to 300 ml in nuclease-free water.
Protein extraction
Total soluble protein was extracted from C2C12 cells by the addition of lysis buffer (10 mM Tris (pH 8 . 0), 150 mM NaCl, 1% Triton X-100 and 5 mM EDTA) containing protease 'cocktail' inhibitors (Rosch). Lysates were passed through a 26-gauge needle and centrifuged at 10 000 g for 20 min. The supernatant was collected and total protein concentration was determined by the bicinchoninic acid (BCA) as outlined by manufacturer's instructions (Pierce Biotechnology Inc., Rockford, IL, USA).
Transient transfections
Each well of a 24-well plate of COS-1 cells (w60% confluence) was transfected with a total of w0 . 6-1 . 0 mg of DNA per well using the liposome-mediated transfection procedure as described previously (Lau et al. 1999) . Briefly, cells were transfected using an N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium methylsulphate and metafectene (Biontex Laboratories GmbH, Munich, Germany) liposome mixture in 1! HBS (HEPES-buffered saline; 42 mM HEPES, 275 mM NaCl, 10 mM KCl, 0 . 4 mM Na 2 HPO 4 and 11 mM dextrose (pH 7 . 1)). The DNA/N-[1-(2,3-dioleoyloxy)-propyl]-N,N,N-trimethylammonium methylsulphate/ metafectene mixture was added to the cells in 0 . 5-0 . 6 ml DMEM supplemented with 10% fetal calf serum.
The culture medium was changed 16-24 h later and the cells were subsequently harvested for the assay of luciferase activity 48 h after the transfection period. Fold activation is expressed relative to activity obtained after co-transfection of the promoter-reporter and pSG5/pNL-VP16 vectors only, arbitrarily set at 1. The mean fold activation values and S.D. were derived from a minimum of three independent triplicate experiments.
C2C12 stable transfection
Myogenic C2C12 cells, cultured in growth medium, were co-transfected with pSG5-RORgDH12, pSG5-RORg and pNL-VP16-RORg (and pCMVNEO at a 20:1 ratio of expression vector/NEO vector) by the liposome-mediated procedure in triplicates. The cells were then grown for another 24 h to allow cell recovery and neomycin resistance expression before G418 selection. After 10-to 14-day selection with 700 mg/ml G418 (Promega) in culture medium, the three independent polyclonal pools of stable transfectants were cultured and maintained on 300 mg/ml G418 medium.
Primers
Primers used for qPCR analysis of the mRNA populations have been described in detail (Lau et al. 2004) , with the exception of primers designed for the detection of endogenous RORg using SYBR green (endo RORg forward, CCCGCCACTCTATAAGGAACTCT and endo RORg reverse, AGGGCTGAAGGA AATAGAAAGTTGT).
Plasmids pSG5-RORa1, mPCP-2x4-tk-LUC(RORaRE) containing four copies of mouse PCP-2 (GTTATAGTAAC-TGGGTCAGGGGACT) and pSG5 have been described previously (Lau et al. 2004) . Mouse RORg1 cDNAs were amplified from C2C12 total RNA using Pfu Turbo (Stratagene) as per manufacturer's instructions and subsequently cloned into pBluescript. After DNA sequencing, this insert was cloned into eukaryotic expression vectors pSG5 and pNL-VP16. Subsequently, a truncated version of RORg was amplified (coding 1-494 aa) and cloned into pSG5 vectors and used as dominant negative form of RORg. 7!(RORgRE)-tk-LUC containing seven copies of RORgRE (GGTAAGTAGGTCAT) was cloned into pTKLuc as described by Medvedev et al. (1996) . The human LPL promoter (K1980 bp) in pGL2 reporter vector was kindly provided by Dr Bart Staels (Schoonjans et al. 1996) . The human Rev-erba promoter (K1733 bp) in pGL2 reporter vector was kindly provided by Dr Vincent Laudet (Adelmant et al. 1996) . The mouse myogenin promoter (K1565 bp) in pCAT reporter was kindly provided by Dr E N Olson (Edmondson et al. 1992) and, subsequently, it was sub-cloned into pGL2 reporter vector in our laboratory.
Quantitative real-time PCR (qPCR) qPCR was performed on an ABI Prism 7500 sequence (detection system (Applied Biosystems, Foster city, CA, USA) in triplicate on three independent RNA preparations. Target cDNA levels were analysed in 25 ml reactions with either Syber Green or Taqman Technologies (Applied Biosystems). Primers (200 nM) used for the amplification of target gene sequences have been described in detail (Lau et al. 2004 , Ramakrishnan et al. 2005 . PCR was performed with 5 ml cDNA and 45 cycles of 95 8C for 15 s and 60 8C for 1 min. The relative level of expression or fold change and associated errors were calculated using the guidelines described by Bookout & Mangelsdorf (2003) on the Nuclear Receptor Signaling Atlas website (NURSA; www.nursa.org/index.cfm) in accord with the accepted qPCR standards for the National Institutes of Health supported NURSA research.
Western blot analysis
Total soluble protein from the wild-type C2C12 myotubes stable pSG5-RORgDH12, pSG5-RORg and pNL-VP16-RORg C2C12 myotubes were resolved on a 10% SDS-PAGE gel and transferred to a nitrocellulose membrane. The membranes were blocked overnight or for 1 h in 5% skimmed milk in TBS-Tween 20 followed by an overnight incubation with either RORg (1:5000, Santa Cruz-28559; Santa Cruz Biotechnology Inc., Santa Cruz, CA, 95060, USA) or RORa (1:2000, Santa Cruz 28612), and GAPDH (1:10 000; R&D Systems, Minneapolis, MN, USA) antibodies. Following 4!15-min washes, the membrane was incubated with anti-rabbit horseradish peroxidase (HRP) (1:2000) for 1 h. Immunoreactive signals were detected using enhanced chemiluminescence Super Signal West Pico Substrate (Pierce) and visualized by autoradiography on an XOMAT film developer (Kodak).
Measurement of ROS
Ten-thousand stable C2C12 cells/well were seeded in a 96-well view plate (Perkin-Elmer) and grown in normal cultured medium (DMEM) with 10% serum. Confluent myoblasts were differentiated into post-mitotic multinucleated myotubes by 5 days of serum withdrawal. Myotubes were loaded with 15 mM H 2 DCFDA (ROS probe, Invitrogen) in phenol red-free media for 30 min at 37 8C and fluorescence was measured. To induce ROS production, after loading ROS probe, we treated the cells with 50 mM H 2 O 2 for about 30 min. The results obtained are from three independent polyclonal pools, assayed in triplicate.
Results
The RORg mRNA and protein are expressed in a differentiation-dependent manner during skeletal muscle differentiation
We initially investigated the expression of RORg mRNA (and protein) relative to GAPDH in the mouse C2C12 in vitro skeletal muscle cell culture model. Proliferating myoblasts can be induced to biochemically and morphologically differentiate into post-mitotic multinucleated myotubes by mitogen withdrawal over several days. This transition from a non-muscle to a contractile phenotype is associated with the activation and repression of a structurally diverse group of genes that are responsible for the contractile and energy demands on this tissue. We utilized qPCR and western blot analysis to show that RORg mRNA and protein expression (relative to GAPDH) increased during skeletal muscle cell differentiation (Fig. 1A) .
The differentiation-dependent RORg (mRNA and protein) expression was concomitant with the expression of several (muscle specific) contractile and metabolic markers. For example, qPCR demonstrated concomitant induction of myogenin mRNA (a gene that encodes the hierarchical basic helix loop regulator), slow (type I) and fast (type II) isoforms of the contractile protein troponin I (Fig. 1B-D) . Similarly, differentiation-dependent expression of the genes involved in metabolism (and regulation) of muscle mass was observed. For instance, fatty acid translocase (CD36), FABP4, myostatin and uncoupling protein 3 (UCP3; Fig. 1E -H).
VP16-RORg and RORgDH12 operate as gain and loss of function vectors
To investigate the metabolic role of RORg in skeletal muscle cells by gain and loss of function strategies, we proceeded to design vectors (for ectopic expression) that enhanced and/or attenuated RORg expression function. In order to construct the constitutively activated RORg (gain of function) vector, we cloned the VP16 transactivation domain (411-456 aa) to the N-terminus of RORg ( Fig. 2A) . We utilized VP16-activated receptor because it still remains unknown whether a natural agonist/ligand exists for the RORg nuclear orphan receptor. Hypothetically, this fusion would produce a hyperactive receptor. This approach has been used to mimic ligand/agonistactivated nuclear receptor (Schreiber et al. 2004 , Wang et al. 2004 ). In addition, to perturb RORg function and to disrupt RORg-mediated gene expression, we constructed the RORgDH12 (dominant negative) expression vector. This construct encodes amino acids 1-494 and consequently lacks helix 12 (H12) of the ligand binding domain (LBD) that encodes the AF2 transactivation domain ( Fig. 2A) . The AF2 domain contains the LYKELF aromatic amino acid residues and is conserved in all members of the ROR family. These aromatic amino acid residues are a crucial component for recruiting co-factors containing LXXLL motifs (Xie et al. 2005) . To measure the RORgmediated transactivation on reporter gene, we constructed the heterologous reporter vector containing seven copies of RORgE (GGTAAGTAGGTCAT) in pTKLuc (Medvedev et al. 1996) .
Initially, we demonstrated that the constitutively active RORg vector (VP16-RORg) significantly increased transactivation of the synthetic reporter in COS-1 cells relative to the native RORg-mediated transactivation (Fig. 2B) . Subsequently, we demonstrated that the loss of function vector suppressed native RORg-mediated transactivation of a heterologous reporter in COS-1 cells (Fig. 2C) . Further, the loss of function vector operated in a dominant negative manner and repressed the RORgmediated transactivation of the synthetic reporter in a dose-dependent manner (Fig. 2D ).
Stable ectopic native RORg, VP16-RORg and RORgDH12 expression modulates endogenous RORg mRNA expression
Further, native RORg, VP16-RORg and pSG5-RORgDH12 expression vectors were transfected into skeletal muscle cells, and polyclonal pools of cells (to avoid clonal bias) were isolated after 10-14 days of G418 selection. Subsequently, wild-type C2C12 cells, C2:RORgDH12, native C2:RORg and C2:VP16-RORg cell lines were harvested after 5 days of serum withdrawal (nZ3). Initially, we measured total RORg mRNA expression in these stably transfected cell lines relative to RORg mRNA expression in wild-type C2C12 cells. The primers utilized measured total (i.e. both endogenous and ectopic) RORg mRNA expression. This demonstrated that the stably transfected cell line expressed w20-fold more RORg mRNA. In contrast, western blot analysis indicated that RORg protein levels did not correlate with the relative total mRNA levels ( Fig. 3A) . In this context, studies have demonstrated that differential expression of mRNAs encoding contractile proteins in cardiac muscle is not reflected in protein levels (dos Remedios et al. 1996 , Coumans et al. 1997 . It should be noted that the antibody utilized cannot discriminate between endogenous (native) and exogenous hybrid RORg proteins, and therefore reflects total protein levels.
Furthermore, we noticed that although the levels of total RORg mRNA expression were similar (and not significantly different) in the three stable cell lines, endogenous levels of RORg transcripts were significantly reduced in the cell line expressing the dominant negative form of RORg. Correspondingly, the lines that express native RORg and constitutively active RORg, displayed increased levels of endogenous RORg transcripts (Fig. 3B , albeit less than twofold). In conclusion, we have produced stable cell lines that ectopically over-express dominant negative RORg native RORg and constitutively active RORg.
Stable ectopic VP16-RORg expression modulates myogenin mRNA expression
The cell lines that ectopically express the dominant negative, native and activated forms of RORg cell lines were differentiated and retained the potential to morphologically differentiate. In order to confirm that the changes observed in these cell lines were not due to aberrant differentiation, we measured the levels of myogenic markers in RNA from differentiated cells. Comparable expression of the mRNAs encoding the sarcomeric slow troponin I (TNNI1) and fast troponin I (TNNI2) contractile proteins was observed in stable and wild-type myotubes ( Fig. 4A and B) . Similar levels of myogenin transcripts were noticed in the lines that overexpress the dominant negative and native forms of RORg. Curiously, the line that over-expressed constitutively active RORg showed significantly increased levels of myogenin mRNA expression (Fig. 4C) . However, as observed above the increased levels of myogenin mRNA did not impact on contractile protein mRNA expression.
Further, we tested the potential of ROR (a and g) to transactivate the myogenin promoter. We transiently transfected COS-1 cells with the reporter plasmid containing K1565 bp of the myogenin promoter and examined the effect of co-transfected (exogenous) were co-transfected with 0 . 5 mg synthetic reporter, 1 . 0 mg of each of pSG5, pSG5-RORg and pSG5-RORgDH12. pSG5 was added to normalize the final amount of DNA transfected to 3 mg in three wells of 24-well plate. Significance was calculated using one-way ANOVA and Bonferroni's multiple comparison test where **P!0 . 001. (D) Dominant negative RORg suppresses the RORg-mediated transactivation of heterologous reporter containing RORg-responsive elements in dose-dependent manner. COS-1 cells were co-transfected with 0 . 5 mg synthetic reporter, 1 . 0 mg of each of pSG5, pSG5-RORg and increasing concentrations of pSG5-RORgDH12. pSG5 was added to normalize the final amount of DNA transfected to 3 mg in three wells of 24-well plate. Fold activation is expressed (meanGS.E.M. and derived from three independent (nZ3); each transfection was composed of three replicates). Significance was calculated using Student's t-test where ***P!0 . 0001. S RAICHUR and others . RORg and skeletal muscle metabolism RORg and RORa expression. Interestingly, the myogenin promoter was significantly transactivated by RORg (not RORa) (Fig. 4D) .
Ectopic VP16-RORg expression induces RORa and Rev-erba mRNA expression
We subsequently profiled the expression of several NRs involved in metabolism (Table 1) . This was performed to investigate whether ectopic over-expression of dominant negative, native and activated RORg vectors altered the expression of other NRs.
Interestingly, the cell lines that ectopically expressed native and constitutively active RORg were characterized by significantly increased expression of RORa transcripts (Fig. 5A) . Furthermore, ectopic VP16-RORg induced significantly greater levels of RORa, relative to native RORg expression (Fig. 5A ). Previous studies have demonstrated that RORa regulates Rev-erba expression (Delerive et al. 2002) . Moreover, VP16-RORg expression resulted in a corresponding increase in Rev-erba mRNA expression. This suggested a threshold of RORa expression may be required for the induction of Rev-erba mRNA expression. Surprisingly, the dominant negative form of RORg did not alter RORa or Rev-erba expression.
The profiling of the other NRs involved in metabolism indicated that the effects of ectopic RORg were relatively specific. For example, profiling of many NRs involved in the regulation of lipid homeostasis demonstrated the majority of relevant NRs were refractory to ectopic RORg expression (Table 1) . For example, the expression of liver x receptor (LXR)a and LXRb, peroxisome proliferator activated receptor (PPAR)a, PPARd and PPARg was refractory to the effects of increased RORg (and the corresponding changes in RORa and Rev-erba).
Previous studies have demonstrated that RORa transactivates the Rev-erba promoter (Delerive et al. 2002) . Hence, we co-transfected the Rev-erba promoter with RORa and RORg. This demonstrated that unlike RORa, RORg does not significantly transactivate the Rev-erba promoter (Fig. 5C) . Moreover, it suggests that the increased Rev-erba mRNA expression in these cells (i.e. C2:VP16-RORg) is a reflection of increased RORa (not RORg) mRNA and protein expression. (Table 2) . Interestingly, expression profiling of the cell lines that exogenously expressed native RORg and activated RORg did reveal a functional (and distinct) role of RORg in the regulation of metabolism. Exogenous expression of the native RORg and the activated RORg leads to concordant effects on specific genes. For example, we observed significant activation of GLUT5 mRNA expression in the lines that exogenously expressed native RORg and activated RORg (Fig. 6A) . GLUT5 mRNA encodes the 'fructose-specific' glucose transporter, and its expression is elevated in the muscle from diabetic patients (Stuart et al. 2007 ) and normalized after pioglitazone treatment.
Interestingly, exogenous expression of activated RORg (but not the native RORg) resulted in increased expression of the adiponectin receptor 2 (AdipoR2) mRNA (Fig. 6B) . AdipoR2 is the receptor for adiponectin, an 'adipokine' that regulates glucose uptake and fatty acid oxidation in skeletal muscle (Yamauchi et al. 2003) .
Subsequently, we observed significant activation of IL-15 mRNA expression in the lines that ectopically over-express native RORg and activated RORg cell lines (Fig. 6C) . IL-15 is highly expressed in skeletal muscle and previous studies have demonstrated that IL-15 with ROR (a and g) in non-skeletal muscle cell lines. COS-1 cells were co-transfected with 1 . 8 mg reporter (myogenin promoter), and 0 . 7 mg of each of pSG5, pSG5-RORg and pSG5-RORa. pSG5 was added to normalize the final amount of DNA transfected to 3 mg in three wells of 24-well plate. Fold activation is expressed (meanGS.E.M. and derived from three independent transfections (nZ3); each transfection was composed of three replicates) relative to luciferase activity obtained after co-transfection of the reporter, and pSG5 vector only was arbitrarily set at 1. Significance was calculated using the one-way ANOVA and Tukey's multiple comparison test where **P!0 . 001.
S RAICHUR and others . RORg and skeletal muscle metabolism increases glucose utilization (Busquets et al. 2006 ) and administration of IL-15 to rats and mice inhibits white adipose tissue deposition (Quinn et al. 2005) . In summary, several genes involved in carbohydrate metabolism were modulated by ectopic expression of native and activated RORg. In addition, we observed significant increases in myostatin (and IL-15) mRNA expression in the lines that ectopically over-express native RORg and activated RORg cell lines (Fig. 6C and D) . Myostatin is a negative regulator of muscle mass and positive regulator of adiposity (McPherron et al. 1997 , Thomas et al. 2000 . Moreover, IL-15 has anabolic effects on skeletal muscle protein synthesis both in vivo and in vitro (Quinn et al. 2005) .
Furthermore, we observed that the expression of the mRNA encoding LPL (Fig. 6E ) was significantly enhanced in the lines transfected with the native and constitutively active RORg. LPL is involved in preferential lipid utilization and TG hydrolysis. Subsequently, to understand the molecular mechanisms involved in the significant increase in LPL transcripts in the RORg over-expressing lines, we analyzed the LPL promoter. We transiently transfected COS-1 cells with reporter plasmid containing K1980 bp of LPL promoter and examined the reporter activity after co-transfection of exogenous RORg and RORa plasmids. Interestingly, LPL was significantly transactivated by RORg (not RORa; Fig. 6F ). Thus, we speculate that LPL expression is modulated by RORg expression in skeletal muscle cells.
The expression of the mRNAs encoding CD36 and FABP4 (involved in fatty acid and oxysterol absorption) was significantly attenuated in the stably over-expressing activated RORg cell line relative to the wild type. Surprisingly, the over-expression of the dominant negative and native RORg vectors resulted in increased CD36 and FABP4 mRNA expression ( Fig. 7A and B) .
In summary, analysis of the lines that over-express ectopic native RORg and activated RORg suggested that this orphan NR is involved in the regulation of lipid and carbohydrate homeostasis, and the control of muscle mass. However, the latter observations ( Fig. 7A and B) present us with two apparent paradoxes. First, overexpression of the dominant negative and the native NR produced a similar effect on several target genes (FABP4 and CD36). Secondly, ectopic expression of the native RORg and the activated RORg lead to either opposite or similar effects (for example, see 6A vs 7A) on specific genes. There are a number of possible explanations. As discussed previously, it still remains unknown whether a natural agonist/ligand exists for RORg and this coupled to the observation that agonist-dependent NRs can function as repressors in the absence of ligand complicates the interpretation of native NR overexpression. The issue is further convoluted by several observations that underscore the permutations associated with NR-mediated regulation: i) loss of LXR in mice leads to derepression (increased expression) of ABCA1, a classical target gene, whereas another target gene, SREBP-1c remains silenced (Wagner et al. 2003) ; ii) agonist activation of PPARg and PPARd can lead to transcriptional repression (Lee et al. 2003 , Ghisletti et al. 2007 ; and iii) orphan NRs (e.g. chicken ovalbumin upstream promotor transcriptional factor (COUP-TF)) have been reported to function as either activators and repressors of transcription, or accessory factors. These observations can be partially explained by differential co-repressor/coactivator recruitment and displacement in gene-and cell-specific manner. RORg gain and loss of function studies identify a role for RORg in the regulation of UCP3 mRNA expression and ROS production
We further investigated the physiological role of RORg in skeletal muscle cells by measuring steady-state ATP levels, the rate of fatty acid oxidation and ROS production. Surprisingly, we did not observe any significant change in fatty acid oxidation and total ATP content (data not shown) in the stably overexpressing dominant negative, native and activated RORg cell lines relative to wild-type C2C12 cells. Additional expression profiling revealed that the expression of the mRNA encoding UCP3 (Fig. 8A) was significantly increased in the cell line over-expressing VP16-RORg. UCPs are inner mitochondrial membrane transporters that uncouple substrate oxidation from ATP synthesis, converting fuel to heat. However, many studies have suggested that UCP3 is involved in preferential lipid utilization and modulation of ROS production in skeletal muscle cells. UCP3 knockout mice and adenoviral over-expression in skeletal muscle cells have demonstrated that aberrant UCP3 expression effects ROS production (Vidal-Puig et al. 2000 , MacLellan et al. 2005 . We investigated whether VP16-RORg mediated increases in UCP3 mRNA expression in skeletal muscle cells, altered ROS levels relative to the wild-type (and dominant negative) RORg expression in C2C12 cells. Interestingly, the line that over-expressed ectopic-activated RORg showed a significant decrease in endogenous and (hydrogen peroxide (H 2 O 2 )) induced ROS production relative to the dominant negative and wild-type cells (Fig. 8B ).
Discussion
Genetic, molecular and biochemical studies have demonstrated that RORa has a distinct role in lipid metabolism. For example, RORa-deficient mice develop severe atherosclerosis, hypo-a-lipoproteinaemia, co-transfected with 1 . 8 mg reporter (Rev-erba promoter), 0 . 7 mg of each of pSG5, pSG5-RORg and pSG5-RORa. pSG5 was added to normalize the final amount of DNA transfected to 3 mg in three wells of 24-well plate. Fold activation is expressed (meanGS.E.M. and derived from three independent transfections (nZ3); each transfection was composed of three replicates) relative to luciferase activity obtained after co-transfection of the reporter, and pSG5 vector only was arbitrarily set at 1. Significance was calculated using one-way ANOVA Tukey's multiple comparison test where **P!0 . 001.
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S RAICHUR and others . RORg and skeletal muscle metabolism hypotriglyceridaemia, muscular atrophy and heightened inflammatory responses (Vu-Dac et al. 1997 , Mamontova et al. 1998 , Raspe et al. 1999 , Jetten & Ueda 2002 , Jetten 2004 . In concordance, in vitro cell culture studies indicated that RORa regulates the expression of genes involved in lipid homeostasis in skeletal muscle cells (Lau et al. 2004) .
Although, RORg is highly expressed in skeletal muscle (a major mass peripheral metabolic tissue), the functional role of this orphan NR in metabolism has not been explored. We utilized the C2C12 skeletal muscle cell culture model to investigate whether RORg regulates genetic programmes implicated in metabolism. This in vitro model system is robust and data derived from (Muscat et al. 2002 , Dressel et al. 2003 , Holst et al. 2003 , Wang et al. 2004 . We probed RORg function in skeletal muscle cells by stable ectopic expression of vectors that encode dominant negative, native and activated RORg. The experiments indicated that the RORg dominant negative vector in skeletal muscle cells significantly repressed the endogenous levels of the RORg transcripts, and RORg-dependent gene expression. However, we did not observe any significant change in gene expression involved in metabolism. This is consistent with the phenotype of RORg-deficient mice that appear normal in the context of lipid and carbohydrate homeostasis.
Interestingly, we observed that ectopic overexpression of activated RORg significantly increased the expression of RORa and Rev-erba mRNA. These observations are consistent with the previous reports demonstrating that RORa directly transactivates the Rev-erba promoter (Delerive et al. 2002) .
In the context of carbohydrate metabolism, we observed the lines expressing native and activated Figure 6 qPCR analysis of (A) GLUT5 mRNA, (B) AdipoR mRNA, (C) IL-15 mRNA, (D) myostatin mRNA and (E) LPL mRNA from wildtype C2C12 myotubes and stably transfected dominant negative, native and activated RORg C2C12 myotubes. Normalized mRNA expression is expressed as the meanGS.E.M. of three (nZ3) independent samples, each assayed in triplicate. (F) Analysis of the LPL promoter was performed by co-transfecting with ROR (a and g) in non-skeletal muscle cell lines. COS-1 cells were co-transfected with 1 . 8 mg reporter (LPL promoter), 0 . 7 mg of each of pSG5, pSG5-RORg and pSG5-RORa. pSG5 was added to normalize the final amount of DNA transfected to 3 mg in three wells of 24-well plate. Fold activation is expressed (meanGS.E.M. and derived from three independent transfections (nZ3); each transfection was composed of three replicates) relative to luciferase activity obtained after co-transfection of the reporter, and pSG5 vector only was arbitrarily set at 1. Significance was calculated using one-way ANOVA and Tukey's multiple comparison test where **P!0 . 001. S RAICHUR and others . RORg and skeletal muscle metabolism RORg expressed significantly elevated levels of GLUT5 mRNA. This transcript is increased in skeletal muscle and repressed in adipose in the insulin-resistant diabetic state (Litherland et al. 2004 ) and normalized by pioglitazone therapy. Concordantly, we noted a significant increase in IL-15 mRNA expression that encodes a cytokine expressed in skeletal muscle which induces glucose uptake and oxidation (Busquets et al. 2006) .
Exogenous expression of the VP16-RORg in skeletal muscle cells resulted in the significant elevation of transcripts encoding UCP3, which correlated with attenuated production of ROS. UCPs are inner mitochondrial membrane transporters that uncouple substrate oxidation from ATP synthesis, converting fuel to heat. However, UCP3 has been implicated in the transport of fatty acid anions (Himms-Hagen & Harper 2001) and regulating the accumulation of ROS (Vidal-Puig et al. 2000) . For example, reduced UCP3 expression has been linked to increased ROS production (Vidal-Puig et al. 2000) . Moreover, increased expression minimizes ROS production (MacLellan et al. 2005) . In this context, decreased UCP3 expression in skeletal muscle is associated with insulin resistance in diabetic individuals (Schrauwen et al. 2001 , Patti et al. 2003 , Houstis et al. 2006 . Increased ROS production may critically damage cell membranes and reduce mitochondrial number. In the course of mitochondrial respiration, increased ROS production may lead to deleterious changes in transmembrane potential. Therefore, UCP3 may influence energy expenditure because of a secondary effect on the integrity of the mitochondria (Schrauwen & Hesselink 2002) .
We also demonstrated that the expression of mRNA which encodes myostatin, a negative regulator of skeletal muscle mass and positive regulator of adiposity, is significantly increased in the stable lines which ectopically express native and activated RORg (McPherron et al. 1997) . In this context, we observe elevated levels of IL-15 that have been demonstrated to have anabolic effects in muscle, and decrease white adipose tissue mass in rodents (Quinn et al. 2005) . In summary, it appears that RORg modulates genes involved in the regulation of muscle and adipose mass.
Notably, over-expression of native RORg and chimeric VP16-RORg implicated the orphan NR in the regulation of lipid metabolism. For example, in the RORg gain of function cell lines, we observed elevated LPL mRNA expression. LPL is a ratelimiting enzyme, which hydrolyses the TG-rich lipoproteins into fatty acids in skeletal muscle. Furthermore, we demonstrated that RORg (but not RORa) transactivates the LPL promoter. In the context of lipid homeostasis, we observed significant repression of CD36 and FABP4 mRNAs (that encode proteins involved in fatty acid absorption) in the VP16-RORg cell line. Whether RORg regulates the LPL promoter by primary (direct) and/or secondary mechanisms remain unclear at present. Future studies utilizing ChIP, deletion and EMSA analysis will be used to address these questions.
These latter observations raise questions about the complex mechanisms that mediate the sometimes 
P<0·001
Figure 7 qPCR analysis of (A) CD36 mRNA and (B) FABP4 mRNA from wild-type C2C12 myotubes and stably transfected dominant negative, native and activated RORg C2C12 myotubes. Normalized mRNA expression is expressed as the mean G S.E.M. of three (nZ3) independent samples, each assayed in triplicate. Significance was calculated using one-way ANOVA Tukey's and Dunnett's multiple comparison test where **P!0 . 001. (Kamei et al. 2003 , Rodriguez-Calvo et al. 2006 . Furthermore, gain and loss of NR function can differentially effect target genes (LXR, PPARd and COUP-TF) due to differential cofactor recruitment and displacement in diverse cells and tissues (Lee et al. 2003 , Wagner et al. 2003 ).
In conclusion, we suggest that RORg in the skeletal muscle cells controls several programmes of gene expression that have important roles in the control of muscle growth, lipid and carbohydrate metabolism. Moreover, we present evidence that this orphan NR may modulate mitochondrial function via the UCP3-mediated regulation of ROS production. Measurement of endogenous and induced ROS in wild-type C2C12 myotubes and stably transfected dominant negative and activated RORg C2C12 myotubes. Significance was calculated using one-way ANOVA and Tukey's multiple comparison test where **P!0 . 001.
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